Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-53

Don't worry there will be no hole in one stuff, no big pay day either, and MSB will never be gone. What is needed is a steady climbing - dare I say CSL style progress based on FDA approvals and hungry global governments wanting non drug therapies to relieve their public health budgets for the next 50 years. If such progression gains speed I doubt many (including myself) could imagine the scale of majors wanting to log in to the opportunity! It's not about devaluing Silviu's role, it's about global scale expertise, mega money, logistics and implementation. The financials could be mind boggling as suggested years ago if everything goes to plan. Recent board changes seem to suggest this is the outlook - knitting it all together under the patent umbrella. I am certain the CEO, with advancing age, tired of living out of suitcases and with the pressure of the above, will fall back to a lesser position - say 5% and still loving every minute! Stem cell rock star.